| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.8 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.8 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |